Barrington analyst Michael Petusky maintained a Buy rating on Henry Schein (NASDAQ:HSIC) on Wednesday, setting a price target of $95, which is approximately 18.20% above the...
Henry Schein (HSIC): Q2 Non-GAAP EPS of $1.11 beats by $0.13; GAAP EPS of $1.10 beats by $0.16.Revenue of $2.96B (+76.2% Y/Y) beats by $90M.Press Release
Henry Schein Inc (NASDAQ: HSIC) posts Q2 net sales of $2.97 billion, beating the consensus of $2.89 billion, up 76.2% Y/Y when a significant number of dental and medical practices...
Canopy Growth (NASDAQ:CGC) Corporation CGC is scheduled to report first-quarter fiscal 2022 results on Aug 6, before the opening bell.In the fourth quarter of fiscal 2021, the...
Align (NASDAQ:ALGN) Technology, Inc. ALGN manufactures and markets a system of clear aligner therapy, intra-oral scanners and CAD/CAM (computer-aided design and computer-aided...
Henry Schein (NASDAQ:HSIC), Inc. HSIC recently made a major breakthrough in the line of pandemic response on achieving a $53.4-million national stockpile contract. The contract has...
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Buy | Sell | Sell | Sell | Strong Buy |
| Technical Indicators | Buy | Sell | Strong Sell | Sell | Strong Buy |
| Summary | Buy | Sell | Strong Sell | Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 2,725.00 | 2,727.00 | 2,696.90 | +22.5 | +0.83% | 893.45K | NASDAQ | |||
| 362.97 | 363.90 | 356.90 | +4.05 | +1.13% | 10.25M | NASDAQ | |||
| 4.44 | 4.47 | 4.44 | 0.000 | 0.00% | 0.00 | NYSE | |||
| 45.06 | 45.14 | 44.70 | -0.13 | -0.29% | 23.51M | NYSE | |||
| 169.40 | 169.88 | 165.13 | +2.61 | +1.56% | 354.45K | NYSE | |||
| 23.22 | 23.33 | 23.14 | +0.11 | +0.48% | 2.62M | NYSE | |||
| 20.16 | 20.46 | 20.15 | +0.08 | +0.40% | 826.88K | NYSE | |||
| 80.87 | 82.96 | 80.60 | -0.79 | -0.97% | 603.11K | NASDAQ | |||
| 19.56 | 19.82 | 19.22 | +0.50 | +2.62% | 6.96M | NYSE | |||
| 6.35 | 6.485 | 6.33 | -0.140 | -2.16% | 8.26M | NYSE | |||
| 61.83 | 63.33 | 61.74 | -1.49 | -2.35% | 715.96K | NYSE | |||
| 1.10 | 1.12 | 1.06 | +0.0200 | +1.85% | 4.13M | NYSE | |||
| 53.89 | 54.02 | 53.58 | +0.34 | +0.63% | 15.31M | NASDAQ | |||
| 13.30 | 13.54 | 12.97 | +0.10 | +0.76% | 2.86M | NYSE | |||
| 21.26 | 21.66 | 21.21 | -0.39 | -1.80% | 11.55M | NYSE |
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates in two segments, Health Care Distribution, and Technology and Value-Added Services. The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services. This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins. The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners. This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.